11/05/2026
A Tale of Two Pancreatic Cancer Patients
Both were 62. Both had metastatic pancreatic cancer driven by a KRAS mutation. Both had loving families, similar resources, and access to world-class cancer care.
Both started the same chemotherapy, hoping for one thing: more time with their children and grandchildren.
Six months later, their paths had diverged.
One was in a wheelchair, weakened by treatment and cancer progression, facing fewer options.
The other was home with his family, his cancer stable after moving to a new treatment.
What if the difference was having Plan B ready before Plan A stopped working?
With new therapies like RASONQUE™ creating additional options for eligible pancreatic cancer patients, knowing what comes next—and when— matters.
Inspired by Sid Sijbrandij's personalized cancer playbook, we're building Oncology CoPilot to connect advanced testing, AI-guided insights, specialists, and ongoing monitoring into one evolving treatment roadmap.
Don't wait for Plan A to fail before building Plan B.
Read our latest story about two hypothetical patients and why planning ahead could matter:
Read the Substack - https://oncologycopilot.substack.com/p/a-tale-of-two-pancreatic-cancer-patients?r=25ead6&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
Because every patient deserves more options, more informed decisions, and more hope.
Six Months. Two Very Different Paths.